A Prospective Cohort Study of Myasthenia Gravis in China

RecruitingOBSERVATIONAL

Enrollment

202

Participants

Timeline

Start Date

August 20, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Myasthenia Gravis

Interventions

DRUG

Steroid Drug

Maintaining low-dose oral steroids

OTHER

Withdraw all immunosuppresants

Trial Locations (1)

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER